Trial intelligence / Profile preview

Postoperative management strategies for adenomyosis after conservative surgery

ChiCTR-OPN-17012991Phase 4Recruiting

Sponsor
Tongji Hospital
Start
May 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of avatrombopag in adenomyosis (3 arms), sponsored by Tongji Hospital. Primary endpoints: Pain score and Menstrual bleeding score. Started May 2018; status: recruiting.

02

Drugs

avatrombopag
03

Conditions

adenomyosis

Beyond the preview

Go deeper on ChiCTR-OPN-17012991.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-OPN-17012991.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call